Clinical Trials Logo

Filter by:
NCT ID: NCT05332275 Not yet recruiting - Clinical trials for Substance Related Problem

A Media Parenting Prevention Intervention

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Entertainment media commonly depict SU, and youth exposure to media SU is linked to youth initiation and progression of SU behavior. Parenting practices reduce exposure to and may mitigate risk associated with media depictions of SU, thus this research proposal will build upon current understanding of effective media parenting with the end goal of developing and testing a media parenting intervention designed to reduce youth risk for SU.

NCT ID: NCT05327829 Not yet recruiting - Clinical trials for TBI (Traumatic Brain Injury)

Stimulating After Recovery From Traumatic Brain Injury

SMART
Start date: June 30, 2024
Phase: Early Phase 1
Study type: Interventional

This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) and transcutaneous noninvasive vagal nerve stimulation (tnVNS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.

NCT ID: NCT05326633 Not yet recruiting - Critical Illness Clinical Trials

Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors

ProMoTE
Start date: October 1, 2024
Phase: Early Phase 1
Study type: Interventional

Older ICU survivors with ICU acquired weakness (ICUAW) are malnourished, sarcopenic, and functionally debilitated as a consequence of the high burden of comorbidities common in the elderly. To address the sequalae of critical illnesses, the investigators will perform a trial incorporating an intervention that combines mobility-based physical rehabilitation (MRP), high protein supplementation (HPRO), and neuromuscular electric stimulation (NMES). The investigators will then assess both clinical and functional outcomes and determine the relationship of disability with systemic inflammation.

NCT ID: NCT05326165 Not yet recruiting - Breast Cancer Clinical Trials

Early Intervention

Start date: May 2024
Phase: N/A
Study type: Interventional

This research study is a Pilot Study examining the use of a compression sleeve with embedded sensor to prevent lymphedema.

NCT ID: NCT05325944 Not yet recruiting - Depression Clinical Trials

Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This is a feasibility trial of a digital mental health intervention aimed at young adults (ages 18-25) with nonsuicidal self-injury and who are not currently engaged in mental health treatment. We will pilot three arms: a self-guided DMHI, the DMHI with low-intensity coaching, or an active control which will involve the delivery of non-interactive psychoeducational content via the same app interface. The primary goals of this project are to evaluate the feasibility of the intervention and trial procedures in preparation for a fully-powered randomized-controlled trial.

NCT ID: NCT05324189 Not yet recruiting - Clinical trials for Diabetic Retinopathy

Automated AI-based System for Early Diagnosis of Diabetic Retinopathy

Start date: April 18, 2022
Phase:
Study type: Observational

In this pivotal trial, we aim to perform a prospective study to find the efficacy of iPredict, an artificial intelligence (AI) based software tool on early diagnosis of Diabetic Retinopathy (DR)in the primary care, optometrist and other diabetes-screening clinics. DR is one of the leading causes of blindness in the United States and other developed countries. Every individual with diabetes is at risk of DR. It does not show any symptom until the disease is progressed to advanced stages. If the disease is caught at an early stage, it can be prevented, managed or treated effectively. Currently, screening for DR is done by the Ophthalmologists, which is limited to areas with limited availability. This is also time-consuming and expensive. All of these can be complemented by automated screening and set up the screening in the primary care clinics.

NCT ID: NCT05322213 Not yet recruiting - Type 2 Diabetes Clinical Trials

THC Effects on Glucose in Type 2 Diabetes

Start date: March 1, 2024
Phase: Phase 1
Study type: Interventional

This study will examine the effects THC has on Glucose Metabolism and Endothelial Functioning in participants with Type 2 Diabetes. The participants will complete blood tests and tests to measure energy expenditure, CVD risks, and glucose metabolism. These tests will be performed prior to start of treatment and again after 2-weeks of treatment with the THC or placebo.

NCT ID: NCT05319418 Not yet recruiting - Hypertension Clinical Trials

Effectiveness of BP Remote Monitoring With Virtual Physician Management in Hypertensive Patients.

Start date: April 2022
Phase: N/A
Study type: Interventional

To assess the feasibility and adoptability of DailyDoctor's remote monitoring clinical decision support software tool in helping physicians virtually manage systolic blood pressures among patients with history of stroke or TIA to a target systolic blood pressure (<140 mmHg or a lower target range specified by referring physicians) using remote monitoring and independent clinical judgement.

NCT ID: NCT05318729 Not yet recruiting - Postoperative Pain Clinical Trials

Use of a Vibration Tool for Postoperative Pain Control in Distal Radius Fractures

Start date: March 2025
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine if using a vibration tool improves pain control after surgical treatment of distal radius fracture. Additionally, the investigators would like to determine if this tool has any impact on consumption of pain medications postoperatively.

NCT ID: NCT05317585 Not yet recruiting - Clinical trials for Pregnancy, High Risk

Continuous Glucose Monitor Use in Pregnancy

Start date: October 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.